Kneteman NM - Search Results

1

Human cytomegalovirus infection in humanized liver chimeric mice.

Kawahara T, Lisboa LF, Cader S, Douglas DN, Nourbakhsh M, Pu CH, Lewis JT, Churchill TA, Humar A, Kneteman NM. Kawahara T, et al. Among authors: kneteman nm. Hepatol Res. 2013 Jun;43(6):679-84. doi: 10.1111/j.1872-034X.2012.01116.x. Epub 2013 Feb 26. Hepatol Res. 2013. PMID: 23442000

2

Mice with Chimeric Human Livers and Their Applications.

Douglas DN, Kneteman NM. Douglas DN, et al. Among authors: kneteman nm. Methods Mol Biol. 2019;1911:459-479. doi: 10.1007/978-1-4939-8976-8_32. Methods Mol Biol. 2019. PMID: 30593646 Review.

3

Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease.

Douglas DN, Kawahara T, Sis B, Bond D, Fischer KP, Tyrrell DL, Lewis JT, Kneteman NM. Douglas DN, et al. Among authors: kneteman nm. PLoS One. 2010 Feb 18;5(2):e9209. doi: 10.1371/journal.pone.0009209. PLoS One. 2010. PMID: 20174638 Free PMC article.

4

Critical role of natural killer cells in the rejection of human hepatocytes after xenotransplantation into immunodeficient mice.

Kawahara T, Douglas DN, Lewis J, Lund G, Addison W, Tyrrell DL, Churchill TA, Kneteman NM. Kawahara T, et al. Among authors: kneteman nm. Transpl Int. 2010 Sep;23(9):934-43. doi: 10.1111/j.1432-2277.2010.01063.x. Epub 2010 Feb 17. Transpl Int. 2010. PMID: 20180929 Free article.

5

Factors affecting hepatocyte isolation, engraftment, and replication in an in vivo model.

Kawahara T, Toso C, Douglas DN, Nourbakhsh M, Lewis JT, Tyrrell DL, Lund GA, Churchill TA, Kneteman NM. Kawahara T, et al. Among authors: kneteman nm. Liver Transpl. 2010 Aug;16(8):974-82. doi: 10.1002/lt.22099. Liver Transpl. 2010. PMID: 20677288 Free article.

6

m-TOR inhibitors: what role in liver transplantation?

Kawahara T, Asthana S, Kneteman NM. Kawahara T, et al. Among authors: kneteman nm. J Hepatol. 2011 Dec;55(6):1441-51. doi: 10.1016/j.jhep.2011.06.015. Epub 2011 Jul 23. J Hepatol. 2011. PMID: 21781947 Free article. Review.

7

Impact of calcineurin inhibitors with or without interferon on hepatitis C virus titers in a chimeric mouse model of hepatitis C virus infection.

Kneteman NM, Asthana S, Lewis J, Dibben C, Douglas D, Nourbakhsh M, Tyrrell LJ, Lund G. Kneteman NM, et al. Liver Transpl. 2012 Jan;18(1):38-44. doi: 10.1002/lt.22400. Liver Transpl. 2012. PMID: 21837737 Free article.

8

Arylacetamide deacetylase: a novel host factor with important roles in the lipolysis of cellular triacylglycerol stores, VLDL assembly and HCV production.

Nourbakhsh M, Douglas DN, Pu CH, Lewis JT, Kawahara T, Lisboa LF, Wei E, Asthana S, Quiroga AD, Law LM, Chen C, Addison WR, Nelson R, Houghton M, Lehner R, Kneteman NM. Nourbakhsh M, et al. Among authors: kneteman nm. J Hepatol. 2013 Aug;59(2):336-43. doi: 10.1016/j.jhep.2013.03.022. Epub 2013 Mar 28. J Hepatol. 2013. PMID: 23542347

9

Additive effect of sirolimus and anti-death receptor 5 agonistic antibody against hepatocellular carcinoma.

Kawahara T, Toso C, Yamaguchi K, Cader S, Douglas DN, Nourbakhsh M, Lewis JT, Churchill TA, Yagita H, Kneteman NM. Kawahara T, et al. Among authors: kneteman nm. Liver Int. 2013 Oct;33(9):1441-8. doi: 10.1111/liv.12275. Epub 2013 Jul 29. Liver Int. 2013. PMID: 23895107

10

Generation of improved mouse models for the study of hepatitis C virus.

Douglas DN, Kneteman NM. Douglas DN, et al. Among authors: kneteman nm. Eur J Pharmacol. 2015 Jul 15;759:313-25. doi: 10.1016/j.ejphar.2015.03.022. Epub 2015 Mar 23. Eur J Pharmacol. 2015. PMID: 25814250 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

281 results

Search Page